Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Valenzuela

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 7, 2023
Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized StudyE Michael Lewiecki, Edward Czerwinski, Chris Recknor, et al.
The Journal of Rheumatology|April 16, 2022
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE StudyTien Nguyen, Melvin Churchill, Robert Levin, et al.
The Lancet. Rheumatology|November 2, 2024
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label studyMikkel Østergaard, Mikael Boesen, Walter P Maksymowych, et al.
The Lancet. Rheumatology|June 22, 2026
Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidanceAntonio Ciancio, Andrea Amati, Saviana Gandolfo, et al.
Annals of the Rheumatic Diseases|July 4, 2025
Highly selective tyrosine kinase 2 inhibition with zasocitinib (TAK-279) improves outcomes in patients with active psoriatic arthritis: a randomised phase 2b studyAlan Kivitz, Xenofon Baraliakos, Elena Tomaselli Muensterman, et al.
International Journal of Molecular Sciences|May 11, 2024
Distinct Driver Pathway Enrichments and a High Prevalence of <i>TSC2</i> Mutations in Right Colon Cancer in Chile: A Preliminary Comparative AnalysisCamilo Tapia-Valladares, Guillermo Valenzuela, Evelin González, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Development and evaluation of an <sup>18</sup>F-labeled nanobody to target SARS-CoV-2's spike proteinSara Lopes van den Broek, Rocío García-Vázquez, Ida Vang Andersen, et al.
BMC Musculoskeletal Disorders|February 25, 2025
Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hipStephen J DiMartino, Haitao Gao, Simon Eng, et al.
International Journal of Molecular Sciences|October 16, 2025
Novel Type IIS-Based Library Assembly Technique for Developing Nanobodies Targeting IPNv VP2 ProteinCamila Pino-Belmar, Johanna Himelreichs, Camila Deride, et al.
Elife|November 26, 2025
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)Constanza Salinas-Rebolledo, Javier Blesa, Guillermo Valenzuela-Nieto, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 7, 2023
Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized StudyE Michael Lewiecki, Edward Czerwinski, Chris Recknor, et al.
The Journal of Rheumatology|April 16, 2022
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE StudyTien Nguyen, Melvin Churchill, Robert Levin, et al.
The Lancet. Rheumatology|November 2, 2024
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label studyMikkel Østergaard, Mikael Boesen, Walter P Maksymowych, et al.
The Lancet. Rheumatology|June 22, 2026
Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidanceAntonio Ciancio, Andrea Amati, Saviana Gandolfo, et al.
Annals of the Rheumatic Diseases|July 4, 2025
Highly selective tyrosine kinase 2 inhibition with zasocitinib (TAK-279) improves outcomes in patients with active psoriatic arthritis: a randomised phase 2b studyAlan Kivitz, Xenofon Baraliakos, Elena Tomaselli Muensterman, et al.
International Journal of Molecular Sciences|May 11, 2024
Distinct Driver Pathway Enrichments and a High Prevalence of <i>TSC2</i> Mutations in Right Colon Cancer in Chile: A Preliminary Comparative AnalysisCamilo Tapia-Valladares, Guillermo Valenzuela, Evelin González, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Development and evaluation of an <sup>18</sup>F-labeled nanobody to target SARS-CoV-2's spike proteinSara Lopes van den Broek, Rocío García-Vázquez, Ida Vang Andersen, et al.
BMC Musculoskeletal Disorders|February 25, 2025
Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hipStephen J DiMartino, Haitao Gao, Simon Eng, et al.
International Journal of Molecular Sciences|October 16, 2025
Novel Type IIS-Based Library Assembly Technique for Developing Nanobodies Targeting IPNv VP2 ProteinCamila Pino-Belmar, Johanna Himelreichs, Camila Deride, et al.
Elife|November 26, 2025
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)Constanza Salinas-Rebolledo, Javier Blesa, Guillermo Valenzuela-Nieto, et al.
Pageof 4